Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
Related Posts
Record-Breaking Bitcoin Rally Post-Trump Victory Begins To Cool In Derivatives Trading, What’s Next?
The massive Bitcoin (BTC) rally following Donald Trump’s victory in the US presidential election is beginning to show signs of…
Grayscale stakes $150M ETH as SEC altcoin ETF deadlines approach
Grayscale staked $150 million in Ether after launching the first US crypto ETPs offering staking rewards, ahead of key SEC…
‘Altseason is here’ — 5 things to know in Bitcoin this week
Bitcoin price excitement is fading as altcoins become crypto traders’ new target. Is BTC due for a deeper correction?